health
Liver Load Increase
Adverse effectLiver Load Increase is an adverse health effect involving increased load on the liver. The term describes the effect itself and does not specify a particular symptom a person will notice.
Liver Load Increase describes a health-related effect involving increased load on the liver.
These are research findings, not promises. Most options have little evidence, and results differ from person to person.
What can cause it
How likely each one is to cause it, most likely first.
AcupuncturepracticeUnclear
Based on 3 studies. Strongest study: a pooled analysis of several trials.
Pooled analyses of randomized trials reported abnormal liver function in studies involving people with cancer or Parkinson's Disease; this finding concerns liver-function changes, not a measured increase in liver workload.
Open the Acupuncture pageFastingpracticeUnclear
Based on one study. Strongest study: a systematic review of studies.
A 2023 systematic review of observational studies in people with fatty liver reported increased ALT levels after Ramadan fasting; it did not give the size of the increase.
Open the Fasting pageHot BathpracticeUnclear
Based on one study.
A very long or very hot bath can raise body temperature enough to cause heat stroke, which can injure the liver; liver strain is not expected with normal bath times and temperatures.
Open the Hot Bath page
The expert view shows every study, dose protocol and source.
What can cause it
Interventions reported to bring this on3 listedHighest probability
- →PracticesAcupunctureCertaintyLowSourceClinical3 other sources
Pooled analyses of randomized trials reported abnormal liver function in studies involving people with cancer or Parkinson's Disease; this finding concerns liver-function changes, not a measured increase in liver workload.
Who was studied
- People with a condition
- Cancer
- Parkinsons Disease
Open AcupunctureStudy result
Abnormal liver function
- →PracticesFastingCertaintyLowSourceClinical1 other source
A 2023 systematic review of observational studies in people with fatty liver reported increased ALT levels after Ramadan fasting; it did not give the size of the increase.
Who was studied
- People with a condition
- Fatty Liver Nafld
Open FastingStudy result
Increase in ALT levels after Ramadan fasting
- →PracticesHot BathCertaintyLowSourceReference knowledge1 other source
A very long or very hot bath can raise body temperature enough to cause heat stroke, which can injure the liver; liver strain is not expected with normal bath times and temperatures.
Open Hot BathStudy result
A very long or very hot bath can raise body temperature into heat stroke, and heat stroke can injure the liver; at normal bath times and temperatures no liver strain is expected.
How to read the evidence
Evidence tier — overall strength of the evidence for the whole compound
- StrongWell established — backed by strong, consistent human research.
- ModerateSome genuine support, but mostly from small or lower-quality studies. Promising, not proven.
- PreliminaryEarly-stage evidence — a promising hypothesis, not an established effect yet.
- LimitedVery limited evidence — treat this as a hypothesis, not proof.
- InsufficientNot enough good evidence to draw conclusions yet.
Certainty — how sure we can be that the effect is real
- Very highVery sure — strong, consistent evidence
- HighFairly sure — consistent evidence from good studies
- MediumModerately sure — new studies could change this
- LowNot sure — little or mixed evidence
- Very lowVery unsure — almost no usable evidence
Source — where the data comes from
- Meta-analysisPooled analysis of many trials — the strongest evidence
- RCTRandomized controlled trial — a strong human study design
- ClinicalA human clinical study
- Reference knowledgeFrom general health-science or pharmacology references, not a study of this exact claim
- Animal researchStudied in animals, not humans
- Community reportsAggregated user reports — anecdotal signal, not evidence
- TheoreticalMechanism-based reasoning, not yet tested
Study grade — quality of each underlying study (A best, D weakest)
- AHigh-quality — strong, consistent human trials
- BGood — solid evidence with some limitations
- CModerate — limited, small, or mixed-quality studies
- DWeak — preliminary, indirect, or animal-only
Confidence — how strongly the sources back a finding
A 0–100 score from study quality and agreement
Most supplement evidence is graded C–D. Read it as preliminary signal, not proof.
Full write-up
What is it
Liver Load Increase is an adverse health effect involving increased load on the liver. The term describes the effect itself and does not specify a particular symptom a person will notice. It may be associated with interventions such as Cigarette Smoking, CBD (Cannabidiol), Horny Goat Weed (Epimedium), and Berberine.
How interventions help
For this outcome, the interventions represent potential contributors to increased liver load rather than ways to reduce it. The reported changes are not all equivalent: some involve liver-enzyme elevations, while others involve bilirubin changes, liver-function impairment, or increased risk of NAFLD. This means that “liver load increase” describes a group of related findings rather than one uniform response.
The strongest practical distinction is between ongoing exposure and product-specific use. Active smoking is associated with increased NAFLD risk, while supplement-related signals range from changes in laboratory markers to broader concerns about liver function. The relevance of these findings may also differ by a person’s baseline health; for example, excessive protein intake is described as potentially stressing compromised liver function in people with pre-existing liver disease.
Amount and duration may matter for some interventions. Higher doses of CBD, specifically 10-20 mg/kg/day, were associated with the reported liver-related signal. For Resveratrol, the longer-duration subgroup showed a significant increase, with exposure lasting at least 12 weeks. These findings do not establish that every product or exposure will produce the same response, and they do not show a consistent onset time or whether changes persist after stopping. Most studied health statuses were not specified, so applicability to particular medical conditions, doses, formulations, or patterns of use remains uncertain.
Choosing guidance
These entries should not be treated as interchangeable. The reported outcomes range from changes in liver enzymes to bilirubin elevation, liver function impairment, and increased risk of fatty liver disease. A change in a laboratory marker is not the same outcome as a diagnosed liver condition, so selection should begin with the specific concern being considered rather than with the probability label alone.
The type of evidence also matters. Some options have clinical evidence, including randomized trials or reviews, while others rely on anecdotal reports or a pharmacology reference. Anecdotal and reference-based information can provide context, but it is less direct for judging how consistently an effect occurs in people. Results from a case report or a small study should not be assumed to apply broadly.
Amount and duration can change how an option is interpreted. The CBD signal was reported with higher doses, while the Resveratrol increase appeared in a longer-duration subgroup. This makes dose and length of use particularly relevant when comparing those options. The information for Aloe Vera also specifically concerns prolonged high-dose oral use, whereas other entries do not establish the same exposure pattern.
The populations studied are another limitation: health status was not specified, so it is unclear how these findings apply to people with or without existing liver disease. The Whey Protein reference specifically discusses possible stress on compromised liver function with excessive protein intake, but that does not establish equivalent relevance for everyone. Readers comparing options should therefore weigh the outcome, evidence type, exposure pattern, and personal health context together.